 |
| Bayer Vietnam and its partner committed to provide species health solutions to help farmers. — VNS Photo |
HCM CITY (Biz Hub) — Bayer Vietnam has launched a new vaccine to protect swine from respiratory diseases.
Bayovac®Suishot® APM-7 offers farmers a new solution to protect their pigs against breathing ailments caused by Actinobacillus pleuropneumoniae (APP) serotype 2 and 5 and Pasteurella multocida type A and D.
"Bayer is committed to helping farmers keep their animals healthy and productive," Sylvain Paul Lacladere, country head of animal health at the German company, said.
"We understand the importance of prevention of respiratory diseases to help minimise impacts on the animal and herd, as well as the economic impact on the farmers.
"We are very confident that the launch of this new vaccine will significantly benefit swine farmers in Vietnam."
Respiratory diseases in swine are very common, but, unfortunately, also very difficult to prevent and control.
Swine respiratory diseases can result in the depression of growth rates and feed intake, and sometimes even death.
The bacterium APP consists of at least 15 different serotypes, some of which produce no disease, but others can cause severe disease.
Serotypes vary in different countries. Types 1, 5, 9, 11 and 12 are usually highly virulent, while strains 3 and 6 are mild.
The respiratory disease caused by Pasteurella multocida is infectious.
The bacterium enters the pig and causes haemorrhagic evidence and bleeding in specific areas of the body, and ultimately enters the bloodstream causing blood systemic failure.
The cost for treatment is very hight and it takes a very long time as well for the pig to recover after the treatment. Vaccination is the only specific and most efficient preventive measure.
Bayovac®Suishot® APM-7 is a combo vaccine that protects swine from APP (serotype 2 and 5), Pasteurella multocida (types A and D) and APX I, II, III.
Vaccinated pigs prove the survival ratio from the stage after sucking to finisher around 98-100 per cent and coming 2 to 5 days earlier to the market in comparison to non-vaccinated pigs.
"As part of our company's efforts to support local agricultural growth, we build on our strong partnership with Cavac Korea to bring Bayovac®Suishot® APM-7 to Vietnam to offer Vietnamese breeders a broad variety of products to best serve their individual needs," Lacladere said.
Dr. Jason Lim, technical manager of Cavac Korea, said: "We have worked with Bayer to bring Bayovac®Suishot® APM-7 to Vietnam which will help built up local portfolios to best support producers with solutions along the entire production cycle."
With a long-standing history of innovation, Bayer's expertise in the animal health market allows the company to truly understand and meet customers' needs.
The innovative, technologically superior portfolio of Bayer exemplifies its commitment to providing species health solutions to help farmers.
Recent developments in the swine health market are met by Bayer's vast portfolio of swine medications.— VNS